People age 18 or older with autism spectrum disorder (ASD) and who have a significant mood disorder or other behaviors that interfere with function and quality of life are needed to take part in a Johns Hopkins research study.
The study will last 14 weeks total:
- first six weeks, participants receive a pill containing cannabidiol, or CBD;
- next two to three weeks, participants receive no drug/placebo;
- final six weeks, participants receive the placebo, an inactive pill.
As part of the study, participants will have regular visits and be asked questions about anxiety, challenging behaviors, daily functioning, cognition, and physical symptoms, on standard assessments that are not usually asked in routine clinical care.
Call 410-575-3267 for details.
Principal Investigator: Elizabeth Wise, MD IRB00267739
